Using GLP-1/GIP weight-loss medication? Review intake and function—not weight alone

Using GLP-1/GIP weight-loss medication? Review intake and function—not weight alone

The short answer

If Wegovy, Mounjaro or another obesity medication has sharply reduced your food intake, or you are concerned about nausea, low protein intake, reduced activity or strength, the scale is not enough. Bodyall does not replace the prescribing clinician. We review medication history, symptoms, intake, activity and function; separate the roles of food, resistance activity, lifestyle care and optional herbal medicine; then reassess the same measures.

Who this visit is for

  • People using or considering a GLP-1 or GLP-1/GIP medication
  • People eating or drinking much less because of nausea or prolonged fullness
  • People losing weight but finding standing, walking or exercise harder
  • People who want medication–herb–supplement safety reviewed before combining them

How Bodyall approaches this review

At Bodyall in Suwon, the visit links the drug name, dose, titration date and prescriber plan with gastrointestinal symptoms, hydration, actual food and protein intake, activity, daily function, weight and waist. We explain the separate roles of medication, food, resistance activity, lifestyle care and optional herbal medicine, and compare the same symptoms and functions at follow-up. When adverse effects or prescription changes need attention, we do not tell patients to stop on their own; we prioritize coordination or referral to the prescriber.

What we check at the first visit

1. Medication and safety

Drug, dose, start and titration dates, other diabetes medicines, pregnancy possibility, and relevant gallbladder, pancreas, kidney or liver history.

2. Intake and symptoms

Nausea, vomiting, bowel symptoms, hydration, actual meal volume and protein-containing foods.

3. Weight and function

Weight and waist plus changes in standing up, walking, stairs and exercise performance, recorded with the same questions and movements.

4. Plan and reassessment

Respect the prescriber medication plan, separate food, activity, lifestyle and optional herbal roles, then review the same measures next time.

Separate the role of each component

Weight-loss medication

Prescription, dose changes and discontinuation belong to the prescriber. Bodyall records changes in intake, symptoms and function and helps connect appropriate medical care.

Food and fluids

If large meals are difficult, meal size and frequency, hydration and protein-containing foods are adjusted to the individual. Blanket high-protein advice is not appropriate for everyone, including some people with kidney disease.

Resistance activity

Standing, walking and resistance tasks are progressed from the person current function and symptoms. Dizziness, dehydration or marked weakness requires assessment before exercise progression.

BodyallFit herbal medicine

Considered only when useful after reviewing medicines, pregnancy possibility and liver, kidney and cardiovascular status. It is not claimed to prevent lean-mass loss or restore basal metabolic rate.

Sleep and daily routine

Sleep, meal timing and activity records are reviewed; one feasible change is chosen and its completion and response are checked at follow-up.

What the evidence does—and does not—show

The SURMOUNT-1 body-composition substudy reported that roughly 75% of weight lost with tirzepatide was fat mass and 25% was lean mass. Lean mass is not identical to skeletal muscle, and the result alone does not diagnose sarcopenia, prove a fall in basal metabolic rate or establish benefit from Bodyall herbal medicine. The original paper is PMID 39996356; PMID 40832789 is its published correction. We keep the two records distinct.

Reassess the same measures

At follow-up we compare weight and waist, nausea or vomiting and hydration, actual meal and protein intake, and standing, walking and exercise performance in the same way. If intake or function worsens despite weight change, the plan is revised and the prescriber is contacted when appropriate.

Seek prompt prescriber or emergency assessment for

Persistent severe abdominal pain, repeated vomiting or dehydration, inability to keep food or fluids down, fainting, marked weakness or falls, or suspected hypoglycaemia require prompt medical assessment rather than relying on online guidance.

FAQ

Does loss of lean mass always mean muscle loss?

No. Lean mass includes water and other non-fat tissues as well as skeletal muscle. Sarcopenia assessment also requires strength and function, not body-composition data alone.

Will Bodyall stop or change my GLP-1/GIP medication?

No. Prescribing and dose changes are handled by the prescriber. Bodyall reviews intake, symptoms and function and recommends coordination or referral when needed.

Can herbal medicine prevent muscle loss or a lower BMR?

That cannot be guaranteed. Herbal medicine is optional after a safety review and does not replace adequate food, activity planning or reassessment.

What should I bring to the first visit?

Bring the drug name and dose, start and titration dates, prescriber instructions, recent weight and waist records, gastrointestinal symptoms, and a brief food and activity record.

Related BodyallFit guidance

GLP-1 adverse effects and combination reviewClinician-led behavior change for plateausRelapse prevention and self-efficacy

Bring your medication, symptoms, food and activity record for a coordinated review.

Check appointment availability on Naver ➜

Evidence and correction record

  1. Look M, et al. Body composition changes during weight reduction with tirzepatide in SURMOUNT-1. Diabetes Obes Metab. 2025. PMID: 39996356. PubMed · DOI
  2. Correction to the SURMOUNT-1 body-composition article. Diabetes Obes Metab. 2025. PMID: 40832789. PubMed · DOI

Medical review: Reviewed and approved by Chief Director Donghae Lee (APPROVED) ·